Resistance training improves 2-hour glucose tolerance in older adults with prediabetes, depending on phenotype
Key takeaway:
A 12-week supervised resistance training program improved 2-hour oral glucose tolerance in older adults with IGT or combined IFG/IGT, but not in those with isolated IFG, without dietary changes.
Study at a glance
What was studied
Effect of 12-week resistance training on glucose homeostasis by prediabetes phenotype
Study type
non-randomized clinical trial (non-RCT or NRCT)
duration
Short-Term (≤3 mo)
Intervention
Resistance training
Outcomes
Muscular strength, Waist circumference, Body fat mass, Lean body mass, Fasting glucose, 2-hour plasma glucose, Insulin sensitivity, Glucose incremental area under curve (iAUC)
Funding
Non-industry sponsored
Main effects
↑ Muscular strength (chest press +27%, leg press +18%)
↓ Waist circumference (-1.0%) and body fat (-0.6%)
↑ Lean body mass (+1.3%)
↓ 2-hour glucose in IGT and IFG/IGT subgroups
Evidence Suggest
- Resistance training improved 2-hour glucose tolerance in IGT and combined IFG/IGT subgroups but not isolated IFG
- Body composition improved: waist circumference, body fat decreased and lean mass increased
- Fasting plasma glucose, insulin sensitivity, and glucose AUC did not change significantly
Who this applies to
Older adults (55-65 years) with prediabetes
Keep in Mind
Improvements in glucose tolerance were limited to those with IGT or combined IFG/IGT, not isolated IFG
Between the Lines
- No control group (single-arm pre-post design)
- No HbA1c measurement, potentially missing a prediabetes phenotype
- Indirect measure of insulin sensitivity (Matsuda index) may not detect small changes
- No imaging-based measurement of visceral fat changes
Unlock Full Analysis
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Journal Reference
Eikenberg JD, Savla J, Marinik EL, et al. Prediabetes phenotype influences improvements in glucose homeostasis with resistance training. PLoS ONE. 2016;11(2):e0148009. doi:10.1371/journal.pone.0148009
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.
